| Opella Healthcare Switzerland AG - Telfast 120, überzogene Tabletten | | 54204 | | 02 | | Telfast 120 | | überzogene Tabletten | | R06AX26 | | Fexofenadin | | 26.06.1997 | | |
| | Composition | | fexofenadini hydrochloridum 120 mg, cellulosum microcristallinum, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 0.12 mg, magnesii stearas, Überzug: hypromellosum, polyvidonum K 29-32, E 171, silica colloidalis anhydrica, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | überzogene Tabletten | | | | | Principe actif | Concentr. |
|---|
| Fexofénadine Hydrochloride | 120 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Fexofénadine Hydrochloride | 120 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Amylum Pregelificatum | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Polyvidonum K | 29-32 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | 8.55 | 15.10 | D | LS | Oui | | 036 | 10 Comprimé(s) | 3.16 | 5.60 | D | LS | Oui |
|
|
